A comprehensive review on anti-diabetic property of rice bran

被引:0
|
作者
Bhagavathi Sundaram Sivamaruthi [1 ]
Periyanaina Kesika [1 ]
Chaiyavat Chaiyasut [1 ]
机构
[1] Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University
关键词
Anti-diabetic; Anthocyanins; Rice bran; Rice bran oil; Rice bran extract; γ-oryzanol;
D O I
暂无
中图分类号
R151 [营养学];
学科分类号
100403 ;
摘要
Rice bran(RB) is one of the nutrient-rich agricultural byproducts. It is a composite of carbohydrates, lipids, proteins, fibers, minerals, and trace elements such as phosphorus, potassium, magnesium, calcium and manganese. The extraction and purification process influences the quality and quantity of rice bran oil, which is rich in tocopherols, tocotrienols, 毭-oryzanol, and unsaturated fatty acids. The bioactive components of RB have been reported for exhibiting antioxidant, anti-inflammatory, hypocholesterolemic, anti-cancer, anti-colitis, and antidiabetic properties. In vitro and in vivo studies, and clinical trials in human volunteers revealed the anti-hyperglycemic activity of RB derived compounds. An updated comprehensive review on the antidiabetic property of RB and its derivative is required to appraise the current knowledge in the particular field. Thus, the present paper covered the composition and bioactivities of RB, and influence of extraction methods on the biological property of rice bran oil and rice bran extract. And the current review also focused on the reported antihyperglycemia activity of rice bran derivatives, and its probable mechanism.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 50 条
  • [31] Current anti-diabetic agents and their molecular targets: A review
    Kerru, Nagaraju
    Singh-Pillay, Ashona
    Awolade, Paul
    Singh, Parvesh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 152 : 436 - 488
  • [32] Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property
    Sabu, MC
    Kuttan, R
    JOURNAL OF ETHNOPHARMACOLOGY, 2002, 81 (02) : 155 - 160
  • [33] A comprehensive evaluation of anti-diabetic drugs on nuclear receptor PXR platform
    Singh, Shashi Kala
    Yende, Ashutosh S.
    Ponnusamy, Kalaiarasan
    Tyagi, Rakesh K.
    TOXICOLOGY IN VITRO, 2019, 60 : 347 - 358
  • [34] Anti-diabetic effects of the soluble dietary fiber from tartary buckwheat bran in diabetic mice and their potential mechanisms
    Wu, Weijing
    Li, Zaigui
    Qin, Fei
    Qiu, Ju
    FOOD & NUTRITION RESEARCH, 2021, 65 : 1 - 14
  • [35] Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins
    Malaekeh-Nikouei, Amirhossein
    Shokri-Naei, Sina
    Karbasforoushan, Sobhan
    Bahari, Hossein
    Rahimi, Vafa Baradaran
    Heidari, Reza
    Askari, Vahid Reza
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [36] A review on potential anti-diabetic mechanisms of chitosan and its derivatives
    Priyanka, D. N.
    Prashanth, K. V. Harish
    Tharanathan, R. N.
    CARBOHYDRATE POLYMER TECHNOLOGIES AND APPLICATIONS, 2022, 3
  • [37] Identification of Plant Leaves having Anti-Diabetic Property using Machine Learning
    Pargaien, Amrita Verma
    Singh, Devendra
    Chauhan, Monika
    Negi, Hansi
    Chilwal, Bhawana
    Pargaien, Nirmala
    Proceedings of the 2nd International Conference on Applied Artificial Intelligence and Computing, ICAAIC 2023, 2023, : 195 - 200
  • [38] A Review on the Structure and Anti-Diabetic (Type 2) Functions of β-Glucans
    Wan, Yujun
    Xu, Xiaojuan
    Gilbert, Robert G.
    Sullivan, Mitchell A.
    FOODS, 2022, 11 (01)
  • [39] An updated review on anti-diabetic agents and their functions: a comparative study
    Hussain, Abrar
    Latif, Abdul
    Rehmat, Zainia
    Riaz, Musarat
    Jamil, Nelofer
    Amir, Muhammad
    Asif, Muhammad
    ADVANCEMENTS IN LIFE SCIENCES, 2023, 10 (03): : 326 - 334
  • [40] A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
    Yaribeygi, Habib
    Atkin, Stephen L.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (03) : 328 - 334